A New Look at Old Lesions: Ongoing Research on Chronic Active MS lesions
August 5, 2022
Physicians assess the neurological examination and MRI to determine the stability of a patient with multiple sclerosis (MS). Many times, new lesions will enhance with contrast, which represents new inflammation derived from immune cells moving from the blood into the central nervous system (brain and spine). If a patient has no new lesions, a physician will generally consider them stable and responding to therapy; interestingly, chronic, or older lesions are never considered in this assessment....
Ocrelizumab and Pregnancy in MS Patients
July 22, 2022
Women with multiple sclerosis are many times thinking about having children.They are worried about whether their illness will get worse, they can get pregnant on their medications and whether their children will get multiple sclerosis. Make sure to talk to your MS physician because some of the most important questions involve your particular case, including how active it is, timing of pregnancy and the particular medication you are on to control your illness. Your children will not develop...
Immunosenescence and relevance for MS
July 8, 2022
Immunosenescence refers to age related changes in the immune system. This results in a weaker and more dysregulated immune system. It makes the individual more vulnerable to infections and malignancies and increased risk autoimmunity.Understanding these changes are becoming more and more relevant as life expectancy, including those of patients with multiple sclerosis is becoming longer, with consequences for how MS itself behaves over time and also the implications for disease modifying...
